Asthma

>

Latest News

FDA Accepts Depemokimab BLA for Asthma and Chronic Rhinosinusitis with Nasal Polyps
FDA Accepts Depemokimab BLA for Asthma and Chronic Rhinosinusitis with Nasal Polyps

March 6th 2025

The FDA set the Prescription Drug User Fee Act (PDUFA) date for December 16, 2025.

 Dupilumab, Tezepelumab Gain Ground for Severe Asthma but Overall Biologic Adherence Rates Found Low: 2 Studies from 2025 AAAAI/WAO / image credit ©molekuule.be/stock.adobe.com
Dupilumab, Tezepelumab Gain Ground for Severe Asthma but Overall Biologic Adherence Rates Found Low: 2 Studies from 2025 AAAAI/WAO

February 12th 2025

Postnatal Antibiotics for Maternal Indications May Heighten Childhood Asthma Risk / Image credit: ©DragonImages/AdobeStock
Postnatal Antibiotics for Maternal Indications May Heighten Childhood Asthma Risk

February 12th 2025

 Atopic Dermatitis First, Now Onto Asthma for Enveda's Oral Small Molecule Anti-inflammatory Candidate
Atopic Dermatitis First, Now Onto Asthma for Enveda's Oral Small Molecule Anti-inflammatory Candidate

February 7th 2025

Albuterol/Budesonide Reduces Risk of Exacerbation in People with Intermittent, Mild-Persistent Asthma
Albuterol/Budesonide Reduces Risk of Exacerbation in People with Intermittent, Mild-Persistent Asthma

October 7th 2024

Video Interviews
Podcasts

More News

© 2025 MJH Life Sciences

All rights reserved.